Aleafia Health Inc. is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX: AH.DB), issued on June 27, 2019 and maturing on June 27, 2022.
Further to the Company’s announcement on February 1, 2022, the Forbearance Agreement, entered into between the Company and holders of Convertible Debt representing approximately 58% of the aggregate principal amount of debentures outstanding, has been extended until March 14, 2022. The holders of Convertible Debt representing an additional 4% of the aggregate principal amount of debentures outstanding have subsequently entered into the Forbearance Agreement. The Agreement automatically renews for 14-day periods thereafter unless advance notice to the contrary is provided.
The parties have continued to work expeditiously and in good faith to negotiate a potential transaction to amend the terms associated with the Convertible Debt.
LEARN MORE: www.AleafiaHealth.com
About Aleafia Health
Aleafia Health, a vertically integrated and federally licensed Canadian cannabis company, owns three licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history, and operates a strategically located distribution centre, all in the province of Ontario. The Company produces a diverse portfolio of cannabis derivative products including oils, capsules, edibles, sublingual strips, and vapes, for sale in Canada in the adult-use and medical markets and is pursuing opportunities in select international jurisdictions. The Company owns and operates a virtual network of medical cannabis clinics staffed by physicians and nurse practitioners.
